Ben Brown

Articles

Can Just-in-Time Clinical Trials Reduce Disparities in Participation?

Kashyap Patel, MD;Hirangi Mukhi, BS;Emily Z. Touloukian;Ben Brown

August 16th 2022

Just-in-time trials are 1 tool capable of rapidly increasing access to clinical trials to develop drugs that treat the diverse and unique tapestry of patients across the United States, especially patients with more diverse racial, ethnic, and socioeconomic backgrounds.

Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies

Kashyap Patel, MD;Hirangi Mukhi, BS;Anjana Patel, BSc;Dhwani Mehta, MS;Natasha Clinton, MSN, APRN, AOCNP, BCMAS;Ben Brown;Sara Rogers, PharmD;William Oh, MD;Prasanth Reddy, MD, MPH

February 14th 2022

Advances in the field have also led to the recognition of other clinical challenges, including unforeseen observations and complications associated with choosing the sequencing of appropriate therapeutic interventions as well as the management of drug-related complications.